Cost-effectiveness of FDG-PET
NCT01438164 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2011-09-21
Summary
Evaluation of cost-effectiveness of FDG-PET for the public health system in Brazil.
Conditions
- Oncologic Patients
Sponsors & Collaborators
-
Netherlands: Ministry of Health, Welfare and Sports
collaborator OTHER_GOV -
University of Sao Paulo
lead OTHER
Eligibility
- Min Age
- 13 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-06-30
- Primary Completion
- 2010-06-30
- Completion
- 2011-09-30
More Related Trials
-
FDG-PET/CT for Simulation and Radiation Treatment Planning of Early Breast Cancer
NCT01432002 ·Status: UNKNOWN
-
Positron Emission Tomography (PET) Study for Staging of Muscle Invasive Bladder Cancer
NCT01655745 ·Status: COMPLETED ·Phase: NA
-
Early Versus Late FDG-PET/CT in Bladder Cancer
NCT03065725 ·Status: COMPLETED
-
18F-LN1 PET/CT in Urothelial Carcinomas
NCT06120413 ·Status: RECRUITING
-
18F-FDG PET/CT and Molecular Tumor Characterisation for Staging and Follow-up of Colon Cancer
NCT01636674 ·Status: UNKNOWN ·Phase: NA
-
Comparing 18F-FAPI-04 and 18F-FDG PET/CT in Cancer Detection
NCT06206642 ·Status: COMPLETED ·Phase: NA
-
FDG-PET/CT vs. CT for Monitoring Metastatic Breast Cancer
NCT06877949 ·Status: RECRUITING ·Phase: NA
-
Predictive Value of FDG-TEP During Radiotherapy or Chemo-radiotherapy in Patients With NCSC on the One-year Survival
NCT01261598 ·Status: COMPLETED ·Phase: NA
-
Positron Emission Tomography - Computed Tomography (PET-CT) Scan as a Diagnostic Method in Unknown Primary Tumors
NCT00269373 ·Status: COMPLETED
-
Comparison of PET/CT and Ultrasound in Staging of Malignant Melanoma
NCT04253574 ·Status: COMPLETED
-
PET With Respiratory Gating Technique in Evaluation of Response and Normal Tissue Effect in Thoracic Cancer
NCT02063633 ·Status: UNKNOWN
-
Use of Integrated PET/CT as a First Line Staging and Re-staging Technique in Oncologic Patient.
NCT06168877 ·Status: COMPLETED
-
PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial)
NCT00201942 ·Status: COMPLETED ·Phase: PHASE3
-
F-18-OMFD-PET for Radiotherapy Treatment Planning and Evaluation of Early Therapy Response
NCT00180193 ·Status: TERMINATED
-
Standard Diagnostic Procedures With or Without Fludeoxyglucose F 18 Positron Emission Tomography in Finding Cancer in Patients With a Blood Clot in a Vein
NCT00964275 ·Status: COMPLETED ·Phase: NA
-
Tumor Metabolism of Lung Cancer in Patients Who Underwent Percutaneous Radiation Measured With F-18-FDG-PET
NCT00180154 ·Status: COMPLETED
-
FDG-Positron Emission Tomography (PET)/CT In the Evaluation of Persistent Febrile Neutropenia in Cancer Patients
NCT00707213 ·Status: TERMINATED ·Phase: PHASE1
-
Early Assessment of the Response to Neo-adjuvant Chemotherapy in Breast Cancer Patients With FDG-PET
NCT00904410 ·Status: COMPLETED ·Phase: PHASE4
-
18F-NaF-PET/MR vs 99mTc-MDP-SPECT/CT to Detect Bone Metastases in Prostate Cancer Patients.
NCT02969564 ·Status: COMPLETED
-
68Ga-BNU-PSMA PET/CT in Patients With Various Types of Cancer
NCT04525612 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
18F-FSPG PET/CT Imaging in Patients With Cancers
NCT03144622 ·Status: UNKNOWN
-
Fluorine-18-α-Methyltyrosine Positron Emission Tomography (18F-FMT PET) for Therapy Response in Lung Cancer
NCT00826033 ·Status: COMPLETED
-
Comparative Analysis of SUV Measurements Using Different Correction Methods in Oncological PET/CT Imaging.
NCT07306975 ·Status: NOT_YET_RECRUITING
-
Radiotherapy Planning Based on Positron Emission Tomography With Fluoro-deoxyglucose For Advanced NSCLC
NCT00697333 ·Status: UNKNOWN ·Phase: PHASE2
-
Benefits Study of Respiratory-gated PET Acquisition in Lung Disease
NCT01812031 ·Status: COMPLETED ·Phase: NA